Stock IBRX IMMUNITYBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq
Other stock markets
 21:00:00 07/06/2024 BST 		5-day change 1st Jan Change
6.1 USD +0.16% Intraday chart for ImmunityBio, Inc. -4.98% +21.51%
05-09 ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
IMMUNITYBIO, INC. Stock ImmunityBio, Inc.
 4.22B - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. IBRX Stock
  4. Charts ImmunityBio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW